Extranodal Non-Hodgkin Lymphoma — Trials

Extranodal Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

261 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 46
Recruiting: 18
Ph III recruiting: 1
Growth YoY: —
Industry share: 13%
Top sponsor: Ruijin Hospital
Termination share: 32.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07678229	BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL(BRIDGE-NK)	recruiting	Phase 3	150	Rong TaoOTHER	1	Aug 13, 2026	clinicaltrials
NCT07639879	TR115 VS Investigator's Choice in Relapsed/Refractory Peripheral T/NK Cell Lymphoma	not yet recruiting	Phase 3	180	Tarapeutics Science Inc.INDUSTRY	1	Jun 10, 2026	clinicaltrials